- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有94家主力机构披露2025-12-31报告期持股数据，持仓量总计3082.79万股，占流通A股3.28%
- 波段诊断：
-
技术面诊股
诊断结果：6.7技术面打败了81%的股票
技术面评分前10的股票
近期的平均成本为8.01元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为8.01元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.01","date":1775030239,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2026.04.02","stock":"1.89","trade":"1.12","ind":"-1.60"},{"date":"2026.04.01","stock":"3.66","trade":"4.62","ind":"1.70"},{"date":"2026.03.31","stock":"-0.26","trade":"-0.68","ind":"-1.81"},{"date":"2026.03.30","stock":"2.00","trade":"0.96","ind":"-0.25"},{"date":"2026.03.27","stock":"4.74","trade":"4.54","ind":"1.13"},{"date":"2026.03.26","stock":"0.14","trade":"-0.58","ind":"-1.41"},{"date":"2026.03.25","stock":"-0.14","trade":"1.24","ind":"1.95"},{"date":"2026.03.24","stock":"5.13","trade":"4.01","ind":"1.43"},{"date":"2026.03.23","stock":"-5.67","trade":"-5.71","ind":"-3.76"},{"date":"2026.03.20","stock":"-2.82","trade":"-2.21","ind":"-0.25"},{"date":"2026.03.19","stock":"-1.85","trade":"-2.44","ind":"-2.02"},{"date":"2026.03.18","stock":"0.66","trade":"0.78","ind":"1.05"},{"date":"2026.03.17","stock":"-0.53","trade":"-0.82","ind":"-1.87"},{"date":"2026.03.16","stock":"0.80","trade":"0.60","ind":"0.19"},{"date":"2026.03.13","stock":"-0.53","trade":"-0.10","ind":"-0.65"},{"date":"2026.03.12","stock":"-0.40","trade":"-0.73","ind":"-0.63"},{"date":"2026.03.11","stock":"-0.66","trade":"-0.51","ind":"0.78"},{"date":"2026.03.10","stock":"1.19","trade":"2.00","ind":"2.04"},{"date":"2026.03.09","stock":"-1.18","trade":"-0.66","ind":"-0.74"},{"date":"2026.03.06","stock":"3.81","trade":"3.02","ind":"0.59"},{"date":"2026.03.05","stock":"0.55","trade":"1.11","ind":"1.23"}]
千红制药,深证成指,化学制药指数
压力支撑
该股压力位为7.96元，支撑位为7.75元。
[{"text":"\u538b\u529b\u4f4d","value":"7.96","date":1775059200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.75","date":1775059200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.1资金面打败了68%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金流入较多，投资者可加强关注该行业的个股。
更新时间：04月02日 20:30
| 机构今日流向(万元) | -391.69 | 机构5日流向(万元) | 6842.89 |
| 机构10日流向(万元) | 2134.84 | 机构20日流向(万元) | 1786.39 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少7885.74万股，其中基金净减仓5家，主力净减仓18家，请投资者中长期谨慎为宜。
截止2025-12-31，共94家主力机构（基金94家），持仓量总计3082.79万股，占流通A股3.28%
其中，基金持仓与2025-06-30相比：
增仓：11家 ，增持 288.55万股
减仓：16家 ，减持 34.54万股
新出现在主力名单中：65家 ，持有1034.71万股
从主力名单中消失：83家 ，原持有9174.46万股
其中，基金持仓与2025-06-30相比：
增仓：11家 ，增持 288.55万股
减仓：16家 ，减持 34.54万股
新出现在主力名单中：65家 ，持有1034.71万股
从主力名单中消失：83家 ，原持有9174.46万股
消息面诊股
诊断结果：5消息面打败了26%的股票
今日有利好新闻的公司
近期该股消息很少，消息面信号较弱。
更多>>个股资讯
- 千红制药：河南千牧项目已按计划于2025年7月正式
2026-04-01 - 英矽智能×礼来达成AI制药重磅合作，生物科技ETF
2026-03-30 - 千红制药：公司原创一类新药QHRD106项目处于科
2026-03-30 - 千红制药：公司尚未收到方圆制药项目的管辖法院出具的
2026-03-24 - 千红制药：千红湖北生化制药生产基地项目目前正在紧锣
2026-03-24 - 千红制药：举全公司之力聚焦创新药物研发进程
2026-03-12 - 千红制药：公司将严格按照证监会、交易所相关规则的要
2026-02-27 - 千红制药员工持股计划完成过户 可转债申请获受理
2026-02-12 - 千红制药：已有多个原创一类新药处于有序推进临时试验
2026-02-12 - 千红制药：目前可转债发行相关工作正在积极有序推进中
2026-02-05
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-25 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-14 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-09-13 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-09-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 利好 | 分红转增 | 10派1.2元(含税) | 2025-04-19 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：8.1行业面打败了99%的股票
化学制药行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2026.04.02","price":"-1.60","value":"1.12"},{"date":"2026.04.01","price":"1.70","value":"4.62"},{"date":"2026.03.31","price":"-1.81","value":"-0.68"},{"date":"2026.03.30","price":"-0.25","value":"0.96"},{"date":"2026.03.27","price":"1.13","value":"4.54"},{"date":"2026.03.26","price":"-1.41","value":"-0.58"},{"date":"2026.03.25","price":"1.95","value":"1.24"},{"date":"2026.03.24","price":"1.43","value":"4.01"},{"date":"2026.03.23","price":"-3.76","value":"-5.71"},{"date":"2026.03.20","price":"-0.25","value":"-2.21"},{"date":"2026.03.19","price":"-2.02","value":"-2.44"},{"date":"2026.03.18","price":"1.05","value":"0.78"},{"date":"2026.03.17","price":"-1.87","value":"-0.82"},{"date":"2026.03.16","price":"0.19","value":"0.60"},{"date":"2026.03.13","price":"-0.65","value":"-0.10"},{"date":"2026.03.12","price":"-0.63","value":"-0.73"},{"date":"2026.03.11","price":"0.78","value":"-0.51"},{"date":"2026.03.10","price":"2.04","value":"2.00"},{"date":"2026.03.09","price":"-0.74","value":"-0.66"},{"date":"2026.03.06","price":"0.59","value":"3.02"},{"date":"2026.03.05","price":"1.23","value":"1.11"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 美诺华 | 105.64% | 18.81% | 6.3分 |
| 2 | ST景峰 | 84.77% | 1.62% | 5.5分 |
| 3 | 津药药业 | 55.77% | 60.91% | 6.0分 |
| 4 | 华纳药厂 | 51.60% | 29.66% | 6.7分 |
| 5 | 信立泰 | 41.94% | 21.42% | 6.8分 |
| 6 | 苑东生物 | 39.61% | 24.64% | 7.1分 |
| 8 | 联环药业 | 38.76% | 32.09% | 6.2分 |
| 10 | 舒泰神 | 32.20% | 42.37% | 6.5分 |
| 12 | 海思科 | 31.03% | 12.75% | 6.4分 |
| 14 | 东诚药业 | 26.12% | 22.91% | 6.2分 |
| 16 | 翰宇药业 | 22.85% | 13.00% | 6.1分 |
| 18 | 昂利康 | 21.96% | 25.31% | 6.2分 |
| 20 | 富祥药业 | 21.49% | 0.54% | 5.5分 |
| 22 | 一品红 | 21.11% | 24.46% | 6.3分 |
| 24 | 科伦药业 | 20.05% | 13.20% | 6.3分 |
| 26 | 誉衡药业 | 17.54% | 21.27% | 7.1分 |
| 28 | 益方生物 | 17.18% | 30.65% | 6.2分 |
| 30 | - | 15.77% | 32.58% | 分 |
| 32 | 亚太药业 | 14.78% | 22.35% | 5.3分 |
| 34 | 吉贝尔 | 14.60% | 13.40% | 5.8分 |
| 36 | 司太立 | 13.88% | 5.92% | 5.2分 |
| 38 | 首药控股 | 12.61% | 21.48% | 5.8分 |
| 40 | 莱美药业 | 11.96% | 11.27% | 5.9分 |
| 42 | 康芝药业 | 11.36% | 22.07% | 5.8分 |
| 44 | 前沿生物 | 10.90% | 12.87% | 5.3分 |
| 46 | 灵康药业 | 10.48% | 11.75% | 6.3分 |
| 48 | 奥翔药业 | 10.41% | 3.98% | 5.4分 |
| 50 | 罗欣药业 | 10.11% | 12.04% | 6.5分 |
| 52 | 海欣股份 | 9.39% | 9.67% | 5.9分 |
| 54 | 华东医药 | 9.08% | 10.09% | 6.3分 |
| 56 | 海创药业 | 8.69% | 16.37% | 5.4分 |
| 58 | 贝达药业 | 8.11% | 11.59% | 6.0分 |
| 60 | 普洛药业 | 7.78% | 8.03% | 5.8分 |
| 62 | 海正药业 | 7.72% | 8.81% | 6.2分 |
| 64 | 神奇制药 | 7.26% | 16.26% | 7.1分 |
| 66 | 恒瑞医药 | 6.79% | 11.12% | 7.0分 |
| 68 | - | 6.24% | 19.34% | 分 |
| 70 | 中关村 | 6.18% | 8.55% | 6.3分 |
| 72 | 健友股份 | 5.74% | 5.51% | 6.2分 |
| 74 | 西点药业 | 5.56% | 9.54% | 5.7分 |
| 76 | 华润双鹤 | 5.30% | 4.54% | 6.8分 |
| 78 | 同和药业 | 4.94% | 9.81% | 5.9分 |
| 80 | 华北制药 | 4.59% | 8.99% | 6.2分 |
| 82 | 微芯生物 | 4.10% | 7.95% | 6.3分 |
| 84 | 哈药股份 | 4.05% | 8.11% | 6.1分 |
| 86 | 川宁生物 | 3.69% | 2.24% | 5.1分 |
| 88 | 南新制药 | 3.54% | 11.73% | 5.4分 |
| 90 | 山河药辅 | 3.22% | 6.81% | 5.5分 |
| 92 | 卫信康 | 3.21% | 7.25% | 5.9分 |
| 94 | 新天地 | 3.16% | 8.12% | 5.6分 |
| 96 | 艾力斯 | 3.00% | 8.47% | 6.5分 |
| 98 | 天宇股份 | 2.91% | 7.86% | 5.9分 |
| 100 | 亚虹医药 | 2.29% | 11.20% | 5.7分 |
| 102 | 宣泰医药 | 2.19% | 7.57% | 5.4分 |
| 104 | 圣诺生物 | 1.87% | 15.06% | 6.0分 |
| 106 | 德展健康 | 1.68% | 10.67% | 5.1分 |
| 108 | 仙琚制药 | 1.44% | 5.04% | 6.4分 |
| 110 | 福安药业 | 1.18% | 8.88% | 5.5分 |
| 112 | 纳微科技 | 1.09% | 7.46% | 5.7分 |
| 114 | *ST三圣 | 0.91% | -0.89% | 4.8分 |
| 116 | - | 0.72% | 13.68% | 分 |
| 118 | 金城医药 | 0.40% | 7.58% | 6.1分 |
| 120 | 海南海药 | 0.35% | 7.97% | 5.9分 |
| 122 | 天新药业 | 0.18% | 4.56% | 5.3分 |
| 124 | *ST惠程 | 0.00% | 0.75% | 4.7分 |
| 126 | 新华制药 | -0.13% | 5.22% | 5.7分 |
| 128 | 华邦健康 | -0.56% | 5.14% | 5.4分 |
| 130 | 河化股份 | -1.12% | 2.92% | 5.6分 |
| 132 | 溢多利 | -1.50% | 3.31% | 4.3分 |
| 134 | - | -2.18% | 9.16% | 分 |
| 136 | - | -2.53% | 10.61% | 分 |
| 138 | 易明医药 | -2.96% | 6.12% | 6.6分 |
| 140 | ST人福 | -3.27% | 3.38% | 5.8分 |
| 142 | 国邦医药 | -3.30% | -4.42% | 5.9分 |
| 144 | 汉商集团 | -4.29% | 7.52% | 5.9分 |
| 146 | - | -4.53% | 9.25% | 分 |
| 148 | ST天圣 | -5.90% | -0.58% | 5.0分 |
| 150 | 向日葵 | -6.59% | 4.05% | 5.0分 |
| 152 | ST复华 | -6.94% | 4.22% | 4.3分 |
| 154 | ST诺泰 | -8.06% | 5.10% | 4.7分 |
| 156 | 能特科技 | -13.79% | -5.96% | 5.2分 |
| 158 | 多瑞医药 | -23.13% | -17.50% | 4.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 8/219 ， 55/219。
[{"date":"2025-09-30","value":"14.55","vol":"1.50"},{"date":"2025-06-30","value":"10.03","vol":"1.22"},{"date":"2025-03-31","value":"6.20","vol":"-0.14"},{"date":"2024-12-31","value":"14.32","vol":"19.49"},{"date":"2024-09-30","value":"12.56","vol":"4.59"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
14.55 | 10.03 | 6.20 | 14.32 | 12.56 |
| 行业(%) | 1.50 | 1.22 | -0.14 | 19.49 | 4.59 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"57.71","vol":"49.37"},{"date":"2025-06-30","value":"56.31","vol":"49.34"},{"date":"2025-03-31","value":"54.40","vol":"49.16"},{"date":"2024-12-31","value":"54.85","vol":"50.51"},{"date":"2024-09-30","value":"54.02","vol":"50.38"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
57.71 | 56.31 | 54.40 | 54.85 | 54.02 |
| 行业(%) | 49.37 | 49.34 | 49.16 | 50.51 | 50.38 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 59/219 ， 46/219。
[{"date":"2025-09-30","value":"0.61","vol":"142.64"},{"date":"2025-06-30","value":"0.72","vol":"79.13"},{"date":"2025-03-31","value":"-2.22","vol":"-0.03"},{"date":"2024-12-31","value":"-15.88","vol":"17.80"},{"date":"2024-09-30","value":"-17.62","vol":"45.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.61 | 0.72 | -2.22 | -15.88 | -17.62 |
| 行业(%) | 142.64 | 79.13 | -0.03 | 17.80 | 45.67 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"23.79","vol":"-2.91"},{"date":"2025-06-30","value":"41.17","vol":"58.54"},{"date":"2025-03-31","value":"54.62","vol":"-10.77"},{"date":"2024-12-31","value":"95.77","vol":"-75.44"},{"date":"2024-09-30","value":"56.47","vol":"-34.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
23.79 | 41.17 | 54.62 | 95.77 | 56.47 |
| 行业(%) | -2.91 | 58.54 | -10.77 | -75.44 | -34.88 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 28/219 ， 97/219。
[{"date":"2025-09-30","value":"0.42","vol":"0.31"},{"date":"2025-06-30","value":"0.30","vol":"0.21"},{"date":"2025-03-31","value":"0.16","vol":"0.10"},{"date":"2024-12-31","value":"0.55","vol":"0.43"},{"date":"2024-09-30","value":"0.44","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.42 | 0.30 | 0.16 | 0.55 | 0.44 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.27","vol":"1.94"},{"date":"2025-06-30","value":"0.96","vol":"1.30"},{"date":"2025-03-31","value":"0.52","vol":"0.66"},{"date":"2024-12-31","value":"1.34","vol":"3.18"},{"date":"2024-09-30","value":"1.12","vol":"2.12"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.27 | 0.96 | 0.52 | 1.34 | 1.12 |
| 行业(次) | 1.94 | 1.30 | 0.66 | 3.18 | 2.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"41.19","vol":"4.25"},{"date":"2025-06-30","value":"18.09","vol":"2.97"},{"date":"2025-03-31","value":"15.86","vol":"-26.71"},{"date":"2024-12-31","value":"20.07","vol":"-371.76"},{"date":"2024-09-30","value":"47.32","vol":"-10.28"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 41.19 | 18.09 | 15.86 | 20.07 | 47.32 |
| 行业 | 4.25 | 2.97 | -26.71 | -371.76 | -10.28 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.85","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.30","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.85 | - | 1.30 | - |
| 行业 | 0.00 | 1.71 | 0.00 | 1.99 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 143/219 ， 141/219。
[{"date":"2025-09-30","value":"11.83","vol":"3.48"},{"date":"2025-06-30","value":"11.01","vol":"3.67"},{"date":"2025-03-31","value":"10.22","vol":"3.59"},{"date":"2024-12-31","value":"7.58","vol":"3.34"},{"date":"2024-09-30","value":"8.32","vol":"3.65"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
11.83 | 11.01 | 10.22 | 7.58 | 8.32 |
| 行业 | 3.48 | 3.67 | 3.59 | 3.34 | 3.65 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"8.26","vol":"2.73"},{"date":"2025-06-30","value":"7.01","vol":"2.88"},{"date":"2025-03-31","value":"6.64","vol":"2.81"},{"date":"2024-12-31","value":"4.53","vol":"2.63"},{"date":"2024-09-30","value":"5.46","vol":"2.91"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
8.26 | 7.01 | 6.64 | 4.53 | 5.46 |
| 行业 | 2.73 | 2.88 | 2.81 | 2.63 | 2.91 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 136/219 ， 139/219。
[{"date":"2025-09-30","value":"8.48","vol":"34.03"},{"date":"2025-06-30","value":"8.90","vol":"34.15"},{"date":"2025-03-31","value":"9.29","vol":"34.38"},{"date":"2024-12-31","value":"11.09","vol":"34.54"},{"date":"2024-09-30","value":"10.04","vol":"33.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
8.48 | 8.90 | 9.29 | 11.09 | 10.04 |
| 行业(%) | 34.03 | 34.15 | 34.38 | 34.54 | 33.36 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.09","vol":"1.19"},{"date":"2025-06-30","value":"0.10","vol":"0.88"},{"date":"2025-03-31","value":"0.10","vol":"1.46"},{"date":"2024-12-31","value":"0.12","vol":"0.83"},{"date":"2024-09-30","value":"0.11","vol":"0.72"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.09 | 0.10 | 0.10 | 0.12 | 0.11 |
| 行业(%) | 1.19 | 0.88 | 1.46 | 0.83 | 0.72 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"1.81","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.23","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.82","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.56","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"4.42","blueLineValue":"0.34","type":"YC"}]